Authors

  1. Karamantziani, Theoni MD
  2. Lianou, Loukia MD, PhD, MSc
  3. Zampouni, Dimitra MD, MSc
  4. Koustouki, Vasiliki RN, MSc
  5. Lipsou, Niki MD, PhD
  6. Bouza, Helen MD, PhD

Abstract

Background: COVID-19 infection, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may present with a wide range of clinical presentations and a variety of symptoms in neonates. The cardiovascular manifestations that have been described in the setting of COVID-19 infection in neonates are tachycardia and hypotension, but information regarding cardiac arrhythmias is scarce, while the effect of SARS-CoV-2 on myocardial function is still not well established.

 

Clinical Findings: We present a case of a neonate admitted with fever and nasal congestion.

 

Primary Diagnosis: The neonate was tested positive for SARS-CoV-2. Supraventricular tachycardia (SVT) was diagnosed during his hospitalization in the neonatal intensive care unit.

 

Interventions: The neonate was under treatment with intravenous fluid repletion, intravenous broad-spectrum antibiotics, and continuous hemodynamic monitoring. SVT resolved spontaneously, while the team was preparing application of further supportive measures with a bag of ice on the infant's face.

 

Outcomes: The neonate was discharged in good condition on day 14 post-admission, with no further recurrence of SVT. Follow-up visits were scheduled with the cardiologist.

 

Practice Recommendations: SVT in full-term or premature neonates can be a clinical manifestation of COVID-19 infection. Both neonatologists and neonatal nurse practitioners should be prepared to deal with cardiological manifestations of COVID-19 infection in neonates.